Mark L. Kahn, M.D., B.A.
Professor of Medicine
Department: Medicine
Graduate Group Affiliations
Contact information
11-123 Translational Research Center
3400 Civic Center Boulevard, Bldg. 421
Philadelphia, PA 19104-5159
3400 Civic Center Boulevard, Bldg. 421
Philadelphia, PA 19104-5159
Office: (215) 898-9007
Fax: (215) 573-2094
Fax: (215) 573-2094
Email:
markkahn@mail.med.upenn.edu
markkahn@mail.med.upenn.edu
Publications
Links
Search PubMed for articles
Pharmacological Sciences Graduate Group
Cardiovascular Division Faculty
Kahn Lab (CVI)
Cell and Molecular Biology Graduate Group
Cardiovascular Institute
Search PubMed for articles
Pharmacological Sciences Graduate Group
Cardiovascular Division Faculty
Kahn Lab (CVI)
Cell and Molecular Biology Graduate Group
Cardiovascular Institute
Education:
B.A. (Science)
Brown University, 1984.
M.D. (Internal Medicine)
Brown University School of Medicine, 1987.
Permanent linkB.A. (Science)
Brown University, 1984.
M.D. (Internal Medicine)
Brown University School of Medicine, 1987.
Description of Research Expertise
Research InterestsSignaling pathways in angiogenesis and hemostasis.
Key words: Angiogenesis, vascular development, platelet, signaling.
Description of Research
My laboratory investigates signaling pathways in cardiovascular development and function. We have two general areas of interest: angiogenesis and platelet signaling. In some cases these areas intersect, e.g. the role of Syk and SLP-76 signaling downstream of platelet receptors that regulate lymphatic vascular development. Major projects in the lab include the following: Regulation of lymphatic vascular development by Syk and SLP-76 signaling. Mice lacking Syk or SLP-76 exhibit lethal vascular phenotypes that we have recently found to be due to a failure to separate emerging lymphatic vessels from pre-existing blood vessels. We have recently identified platelet interaction with lymphatic endothelial cells as the basis for this mechanism of vascular regulation. The long term goals of this project are to understand how platelets control endothelial function and lymphatic vascular development. Platelet immunoreceptor signaling. There are two platelet-specific immune-type receptors, GPVI and CLEC2, that activate Syk and SLP-76 signals. GPVI is a collagen receptor that functions in hemostasis and thrombosis. CLEC2 is a receptor for the lymphatic endothelial protein PDPN and regulates blood-lymphatic vascular interactions. We are presently using mouse genetic models to understand how these two receptors signal and to define their biological roles in vivo. Role of cerebral cavernous malformation (CCM) signaling pathway in vascular development and disease. CCMs are a common human vascular disease caused by loss of function mutations in 3 CCM proteins. We have recently shown that the Heart of Glass (HEG) receptor and CCM proteins are required in mouse and fish cardiovascular development. We are actively investigating how this recently identified pathway regulates endothelial function in development and causes CCMs.
Rotation Projects
1. Regulation of lymphatic vascular development by platelet signaling. 2. HEG-CCM signaling in fish and mouse models. 3. Novel receptor signaling pathways in mammalian cardiovascular development. 4. Development and application of lymphatic endothelial-specific gene knockouts.
Lab personnel:
Xiangjain Zheng, PhD-postdoctoral fellow; Zhiyng Zou, PhD-postdoctoral fellow; Cara Bertozzi, PhD student; Chiu-Yu Chen, MD-PhD student; Alec Schmaier, PhD student; Chong Xu, PhD-postdoctoral fellow; Jiping Xiao, PhD-postdoctoral fellow; Patricia Mericko, Lab Manager; Mei Chen Research, Specialist.
Selected Publications
Yuan LJ, Wang T, Kahn ML, Ferrari VA: High-resolution echocardiographic assessment of infarct size and cardiac function in mice with myocardial infarction. Journal of the American Society of Echocardiography Page: 219-26, Feb 2011.Rubio-Garcia J, Coppel Y, Lecante P, Mingotaud C, Chaudret B, Gauffre F, Kahn ML. : One-step synthesis of metallic and metal oxide nanoparticles using amino-PEG oligomers as multi-purpose ligands: size and shape control, and quasi-universal solvent dispersibility. Chemistry Communications (Cambridge England) Page: 988-90, Jan 2011.
Winkelmann R, Sandrock L, Porstner M, Roth E, Mathews M, Hobeika E, Reth M, Kahn ML, Schuh W, Jäck HM.: B cell homeostasis and plasma cell homing controlled by Kruppel-like factor 2. Proceedings of the National Academy of Sciences of the United States of America 108(2): 710-5, Jan 2011 Notes: [Epub 2010, Dec. 27.
Bertozzi CC, Hess PR, Kahn ML.: Platelets: covert regulators of lymphatic development. Arteriosclerosis Thrombosis and Vascular Biology 12: 2368-71, Dec 2010.
Zheng Xiangjian, Xu Chong, Di Lorenzo Annarita, Kleaveland Benjamin, Zou Zhiying, Seiler Christoph, Chen Mei, Cheng Lan, Xiao Jiping, He Jie, Pack Michael A, Sessa William C, Kahn Mark L: CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. The Journal of Clinical Investigation 120(8): 2795-804, Aug 2010.
Bertozzi Cara C, Schmaier Alec A, Mericko Patricia, Hess Paul R, Zou Zhiying, Chen Mei, Chen Chiu-Yu, Xu Bin, Lu Min-min, Zhou Diane, Sebzda Eric, Santore Matthew T, Merianos Demetri J, Stadtfeld Matthias, Flake Alan W, Graf Thomas, Skoda Radek, Maltzman Jonathan S, Koretzky Gary A, Kahn Mark L: Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116(4): 661-70, Jul 2010.
Kahn Mark L: Jazzing up vessel growth. Blood 115(8): 1479, Feb 2010.
Schmaier Alec A, Zou Zhiying, Kazlauskas Arunas, Emert-Sedlak Lori, Fong Karen P, Neeves Keith B, Maloney Sean F, Diamond Scott L, Kunapuli Satya P, Ware Jerry, Brass Lawrence F, Smithgall Thomas E, Saksela Kalle, Kahn Mark L: Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role. Proceedings of the National Academy of Sciences of the United States of America 106(50): 21167-72, Dec 2009.
Schmaier Alec A, Kahn Mark L: Platelet integrin signaling: wherefore art thou? Blood 114(13): 2571-2, Sep 2009.
Zhiying Zou, Alec A. Schmaier, Lan Cheng, Patricia Mericko, S. Kent Dickeson, Thomas P. Stricker, Samuel A. Santoro and Mark L. Kahn: Negative regulation of activated α2 integrins during thrombopoiesis. Blood Jun 2009.

